Amoy Diagnostics Co., Ltd.

SZSE:300685.SZ

19.74 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q22015 Q1
Revenue 307.964232.497334.204248.885263.542195.164242.921206.751186.458206.05271.298246.783225.219173.734244.37200.992192.37490.654165.894146.551146.685119.226128.544107.995113.5988.90387.73293.98486.70661.94971.98867.08456.95856.95835.58635.586
Cost of Revenue 56.28636.25863.62940.87743.67231.48147.38334.25731.48234.68939.48341.68431.80130.30733.92127.42521.98411.61315.76314.90114.40910.63312.17910.8799.5996.7026.5017.9576.2354.5486.3816.2175.3135.3131.9581.958
Gross Profit 251.678196.24270.575208.008219.87163.683195.538172.494154.976171.361231.814205.099193.418143.427210.449173.567170.39179.041150.131131.65132.276108.592116.36597.116103.99182.281.23286.02780.47157.40165.60760.86751.64451.64433.62933.629
Gross Profit Ratio 0.8170.8440.810.8360.8340.8390.8050.8340.8310.8320.8540.8310.8590.8260.8610.8640.8860.8720.9050.8980.9020.9110.9050.8990.9150.9250.9260.9150.9280.9270.9110.9070.9070.9070.9450.945
Reseach & Development Expenses 51.50448.36345.68258.88854.87836.98953.02343.67139.07738.76146.95141.00235.46432.70128.59333.65631.67221.18528.36724.84821.20519.33421.8823.59519.912.96163.05413.20425.399049.31309.8379.8376.896.89
General & Administrative Expenses -6.53720.199-10.95446.004-8.03614.822-7.11337.591-2.5614.6174.27330.1822.39517.92915.80821.27810.71425.074-0.88724.3066.8466.718-7.8776.382-13.78418.547-45.90520.304-14.98318.337-46.40922.89414.90814.90812.54412.544
Selling & Marketing Expenses 94.93865.44106.55378.56490.36554.01195.27978.41568.36261.723114.2774.96670.46143.21795.32266.84649.72921.66573.16646.39852.23248.47656.55242.7137.235.44141.37637.40131.75319.23738.11525.82421.91921.91913.78813.788
SG&A 119.42684.864111.934124.56882.32968.83388.166116.00665.80276.34118.543105.14872.85661.146111.12988.12460.44446.73972.2870.70459.07855.19448.67649.09223.41653.988-4.52957.70616.76937.574-8.29348.71837.71537.71526.81226.812
Other Expenses -7.9640.005-13.664-1.689-1.243-0.113-1.001-0.36-0.208-0.01-0.434-0.7850.227-0.267-0.453-0.301-0.033-0.65-1.09-0.060.1-0.05-0.441-0.991-0.107-0.01-1.190.6280.5910.554.1950.8730000
Operating Expenses 178.895133.222171.281152.633161.97694.704158.252128.28124.309113.41169.847130.473117.13891.442140.115115.15105.44954.325116.31694.10786.28869.0381.82870.48459.97550.95850.74257.28548.67537.82255.95448.96233.48333.48326.38926.389
Operating Income 72.78363.01899.29451.64679.46865.4931.428150.31846.8659.05756.22671.91975.43549.65957.11851.68863.28330.05733.74240.21450.66937.82533.48830.56451.25928.61330.62826.66430.67918.38311.89919.83113.5413.546.6896.689
Operating Income Ratio 0.2360.2710.2970.2080.3020.3360.1290.7270.2510.2870.2070.2910.3350.2860.2340.2570.3290.3320.2030.2740.3450.3170.2610.2830.4510.3220.3490.2840.3540.2970.1650.2960.2380.2380.1880.188
Total Other Income Expenses Net 12.43211.7546.791-1.689-1.243-0.113-1.001-0.36-0.208-0.01-0.434-0.7850.227-0.267-0.453-0.301-0.033-0.65-1.09-0.060.1-0.05-0.441-0.991-0.107-0.01-1.1580.60.5870.554.130.8224.6464.6460.1390.139
Income Before Tax 85.21574.772106.08549.95778.22665.37730.427149.95846.65259.04655.79271.13475.66249.39256.66551.38763.2529.40732.65140.15450.7737.77533.04729.57351.15128.60429.4727.26431.26718.93316.02920.65318.18618.1866.8276.827
Income Before Tax Ratio 0.2770.3220.3170.2010.2970.3350.1250.7250.250.2870.2060.2880.3360.2840.2320.2560.3290.3240.1970.2740.3460.3170.2570.2740.450.3220.3360.290.3610.3060.2230.3080.3190.3190.1920.192
Income Tax Expense 5.29.36713.5472.9848.7828.06-9.70715.3610.4285.709-6.7375.9617.7675.9642.4696.0618.3593.4956.0349.465.1935.1882.1823.2766.5533.6273.2693.4743.6782.4471.4881.9032.12.10.8490.849
Net Income 79.65764.19987.75146.97269.44457.31739.585134.8735.67353.61563.01865.23467.89443.42854.19645.32654.89225.91326.61830.69445.57632.58630.86526.29744.59924.97726.20123.7927.58916.48614.54119.02216.73516.7356.1416.141
Net Income Ratio 0.2590.2760.2630.1890.2640.2940.1630.6520.1910.260.2320.2640.3010.250.2220.2260.2850.2860.160.2090.3110.2730.240.2440.3930.2810.2990.2530.3180.2660.2020.2840.2940.2940.1730.173
EPS 0.20.160.220.120.170.140.110.340.090.130.160.160.170.110.140.120.130.10.070.120.110.0850.0790.0680.120.0630.150.0610.0950.0560.050.0650.0580.0580.0210.021
EPS Diluted 0.20.160.220.120.180.140.110.340.090.130.160.160.170.110.130.120.130.10.070.120.110.0850.0790.0680.120.0630.150.0610.0950.0560.050.0650.0580.0580.0210.021
EBITDA 87.85770.425114.51751.53777.64667.23824.83463.33247.95158.73956.65676.63872.20753.78464.92751.94865.95727.59134.18138.53951.56838.08934.95330.2549.44331.64627.37129.24531.06120.30833.69512.56717.35517.3559.1899.189
EBITDA Ratio 0.2850.3030.3430.2070.2950.3450.1020.3060.2570.2850.2090.3110.3210.310.2660.2580.3430.3040.2060.2630.3520.3190.2720.280.4350.3560.3120.3110.3580.3280.4680.1870.3050.3050.2580.258